The Pharmacodynamics of Switching Between P2Y12 Receptor Antagonists.
The Scripps Clinic and Scripps Translational Science Institute, La Jolla, California. Electronic address: price.matthew@scrippshealth.org.
Matthew J
MJ
Price
D000241:Adenosine; D006801:Humans; D010975:Platelet Aggregation Inhibitors; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12 / Q000187:drug effects; D013988:Ticlopidine
D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D000068799:Prasugrel Hydrochloride; D000241:Adenosine; D013988:Ticlopidine
cangrelor; pharmacodynamics; platelet reactivity; thienopyridine; ticagrelor